A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
NCT07043946
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Immune Thrombocytopenia (ITP)
ITP
Biologics
Monoclonal
Anti-CD19
Interventions
DRUG:
Budoprutug
Sponsor
Climb Bio, Inc.